Experienced management team of subject matter experts across drug development
Prof. Mimi Tang
Chief Executive Officer
Scientific Founder. Clinician researcher, recognized as a global thought leader in allergy, over 330 scientific publications, 25+ years’ experience as a clinical immunologist allergist, research into immune mechanisms driving allergic disease, board and industry advisor.DR MARK HASLETON
Clinical and Commercial Operations
Over 20 years of global biotech / device and pharma experience, management positions at Bristol Myers-Squibb and Teva Pharmaceuticals, and has a doctorate in molecular biology from Imperial College London.Cameron Jones
Chief Financial Officer
Finance executive and Chartered Accountant with experience as CFO and Company Secretary of ASX Listed and private healthcare companies. Has supported companies through IPOs, capital raising and M&A transactions.Kathy Harrison
Director, Intellectual Property
25+ years experience in Australian biotech companies and 9 years in patent attorney practice. Strategic expertise in drug development and intellectual property portfolios.Bronwyn Pollock
Product Development Technical Services - Consultant
Biotech and pharmaceutical professional with 25+ years experience in drug development, quality and program management, submissions to EMA and US FDA. Responsible for all aspects of drug developmentLesley White
Regulatory Affairs & CMC
Accomplished senior leader with more than 30 years’ experience supporting the development of novel pharmaceutical products and preparing global registration dossiers for submission to US FDA, EMA and other major regulatory bodies.Rachelle Kirk-Burnnand
Clinical Operations
Clinical Operations Professional with over 20 years of experience in delivery clinical trials in Australia and globally. Specialising in Phase I-III trials across various therapeutic areas. Has strong leadership, strategic mindset, and passion for achieving goals to deliver Clinical Programs.